Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis

Budak B., Baykara M., Kıvanç S. A., Yilmaz H., Cicek S.

CUTANEOUS AND OCULAR TOXICOLOGY, cilt.35, sa.2, ss.126-130, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.3109/15569527.2015.1058273
  • Dergi Adı: CUTANEOUS AND OCULAR TOXICOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.126-130
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Vancomycin is the gold standard in combination therapy for severe and resistant gram-positive keratitis and in particular for Methicillin-resistant Staphylococcus aureus (MRSA) infections. The aim of this study was to report the ocular surface toxicity and scoring in patients whose treatment shifted to topical linezolid/ceftazidime from topical vancomycin/ceftazidime due to their vancomycin intolerance.